Comparison of Flow Measurement by 4D Flow Magnetic Resonance Imaging and by Particles Image Velocimetry on Phantom of Abdominal Aortic Aneurysm

An 85-year-old gentleman presented with chest pain and sustained ventricular tachycardia and underwent emergency Percutaneous Coronary Intervention (PCI) of his right coronary artery using drug eluting stents.

A staged PCI was planned for the Left Anterior Descending Artery (LAD) three days later. The patient was known to have atrial fibrillation for many years and we planned to occlude the Left Atrial Appendage (LAA) in the same sitting in order to avoid long-term triple therapy.

This study has been designed to investigate the role of phosphatidylinositidyl-3-kinase gamma (PI3Kγ) in Mono Cro Taline (MCT)-and nicotine-induced endothelial dysfunction in pulmonary arteries. MCT (60 mg/ kg, s.c, once in 4 weeks) and nicotine (2 mg/kg, i.p, regularly) were administered in respective groups to produce pulmonary vascular endothelium dysfunction. Vascular endothelial dysfunction was assessed in terms of attenuation of acetylcholine-induced endothelium-dependent relaxation, sodium nitroprusside-induced endothelium-independent vasorelaxation (Isolated pulmonary artery ring preparation), decrease in serum nitrate/ nitrite level, mRNA expression of eNOS (rtPCR) and increased oxidative stress (superoxide anions and TBARS level), mean arterial blood pressure and right ventricular hypertrophy. PI3Kγ inhibitor CAY10505 (0.6 mg/kg, p.o) [(5-[5-4-fluorophenyl)-2-furanyl]-2, 4-thiazolidinedione] and atorvastatin (30 mg/kg, p.o, positive control) treatment for 7 days (21st-28th day) significantly improved, mean arterial blood pressure and right ventricular hypertrophy in both nicotine and Mono Cro Taline-induced pulmonary vascular endothelial dysfunction. Therefore, it may be concluded that CAY10505, a specific inhibitor of PI3Kγ up regulates eNOS expression and nitric oxide production to improve Mono Cro Taline and nicotine-induced pulmonary vascular endothelial dysfunction.

Lymphedema, a condition which typically affects the extremities, is characterized by accumulation of protein-rich fluid in the soft tissues due to malfunction of the lymphatic system. The normal role of the lymphatic system is to passively convey and actively pump interstitial fluid back into the blood stream. Primary (congenital) lymphedema arises from poorly understood factors, while secondary lymphedema is caused by another known disease. Most often, upper extremity secondary lymphedema is the result of breast cancer, with an incidence of 15-20% among female breast-cancer patients who have undergone a mastectomy or radiation as part of therapy [1]. It has been estimated that primary lymphedema affects 1.15 out of 100,000 children in North America [2].

Lymphedema, a condition which typically affects the extremities, is characterized by accumulation of protein-rich fluid in the soft tissues due to malfunction of the lymphatic system. The normal role of the lymphatic system is to passively convey and actively pump interstitial fluid back into the blood stream. Primary (congenital) lymphedema arises from poorly understood factors, while secondary lymphedema is caused by another known disease. Most often, upper extremity secondary lymphedema is the result of breast cancer, with an incidence of 15-20% among female breast-cancer patients who have undergone a mastectomy or radiation as part of therapy [1]. It has been estimated that primary lymphedema affects 1.15 out of 100,000 children in North America [2].

Arrhythmogenic Right Ventricular Cardiomyopathy/dysplasia (ARVC) is a genetic form of cardiomyopathy affecting primarily the Right Ventricle (RV) but also may involves the Left Ventricle (LV) and may culminate in life-threatening ventricular arrhythmias, Sudden Cardiac Death (SCD) and/or heart failure. In most cases it is transmitted with an autosomal dominant pattern of inheritance, with incomplete penetrance and variable expression, but there are also some rare autosomal recessive forms as Naxos disease and Carvajal syndrome.

The term “cardiomyopathy” should be preferred to “dysplasia”, as already suggested by WHO/ International Society and Federation of Cardiology in 1996 and Maron, about classification of cardiomyopathy in 2006 [1,2].

Background: Assessment of tissue oxygenation and vascular function is an integral component in the management of chronic wounds. Current practice in wound centers is screening with Pulse Volume Recording (PVR) or Transcutaneous Oxygen Saturation (TCO₂ ) to evaluate safety of compression wraps, utility for vascular intervention and expected response to Hyperbaric Oxygen Therapy (HBOT).

A near infrared (NIR) spectroscopy device (Kent, Calgary) using 4 wavelengths of light to determine O₂ saturation of hemoglobin (Hgb) in cutaneous tissue has been developed. The low absorption of light by H₂O and melanin in the NIR range allows for measurement of absorption of deoxygenated and oxygenated hemoglobin and for the calculation of O₂ saturation. The purpose of this study is to determine the correlation between the gold standard TCO₂ and NIR spectroscopy in measuring cutaneous O₂ .

Materials and methods: 20 patients with Fitzpatrick skin types I-III who had measurements of TCO₂ (Perimed, Stockholm) also had simultaneous measurements obtained by NIR spectroscopy. The investigation was reviewed and approved by Institutional Review Board for Human Subjects at WVU. The Hemoglobin/ O₂ dissociation curve at 370 degrees C, pH=7.4 and pCO2 =40 was used to calculate O₂ saturations from measurement of TCO₂ .

Results: Data pairs were analyzed using linear regression and the relationship y=0.93 x+5.35 with a correlation coefficient=0.92 and r² =0.84 was calculated.

Conclusions: There was a significant correlation between measurements of tissue oxygenation using TCO₂ and NIR spectroscopy. NIR spectroscopy has the advantage of not requiring skin contact and measurements can be taken even in the wound bed. Other advantages include: 1). Time (2 minutes vs. 90 minutes) and 2). Disposable cost ($150 –TCO₂ vs. $0-NIR spectroscopy). 3). The ability to perform serial studies over time. Further studies are warranted to determine if this information is useful in determining response to HBOT or in predicting wound-healing trajectory

The study aim is to determine factors affecting the long-term survival of subjects with Aortic Aneurysm (AA). The sample included 294 Korean patients aged ≥ 30 years who were hospitalized from 1994 through 2004. Diagnosis was confirmed in 294 AA subjects (18.4% in affected Coronary Artery Disease (CAD); 75.8% with abdominal only AA (AAA) and 24.2% with Thoracic AA (TAA)) by computed tomography angiography in Samsung Medical Center, Seoul, Korea. AA repair direct operation or percutaneous endovascular AA repair (Revascularized group) was performed for 60.3% of the patients. Death data were obtained from all participants between 1994 and 2009. The mean age of AA subjects was 68.7 (±8.1) years. The proportion of males was 82%. Five- and 10-year survival rates were 89.8% and 82.6%, respectively. The 5-and 10-year survival rates were 92.3% and 84.9% in revascularized group and 86.4% and 79.5% in non-revascularized group, respectively. Adjusted hazard ratios were 1.14 (95% Confidence Interval (CI) 1.06-1.22) in ages and 2.94 (95% CI 1.23-7.38) in smoking for AA. Age and smoking contributed to death in Korean AA patients. And the 10-year survival rate for AA patients in Korea was over 80%. Revascularized group shows higher survival rate than non-revascularized group.

Ovarian function is dependent on the establishment and continual remodeling of a complex vascular system. The present review focuses on the ovarian morphological angiogenic processes that involve swine ovarian folliculogenesis and their modulatory molecular mechanisms: from the primordial follicles recruitment to the antral periovulatory stage. The process of angiogenesis, in particular, during the final stage of follicle development (from antral to periovulatory follicular phase) is deepened with a kinetic approach adopted by using an experimental prepubertal model where antral follicle’s selection, growth and ovulation are pharmacologically and timely controlled. Since the cyclicity of follicular angiogenesis is inducible under experimental conditions in several experimental and domestic animals using validated hormonal treatments, it may become a reproducible model to study in vivo molecular mechanisms and pathways involved in angiogenesis and blood vessel remodeling.

The present review has also focused the attention on the regulatory role of vascular endothelial growth factor A in controlling ovarian follicular development as orchestra conductor of the angiogenic process. The main animal model considered in the present review is the pig. The reproductive processes of this domestic animal is of a high translational value by considering the similarity with women of the long periovulatory window (40-44 hours from luteinizing hormone surge to ovulation). This animal model could become, for this reason, a valuable model in understanding the regulatory pathways involved in the final stage of follicular maturation.

Background: The primary aim was to retrospectively assess the incidence of superficial vein thrombosis in a patient cohort that had undergone surgery of the Small Saphenous Vein (SSV) due to Chronic Venous Disease (CVD).

Material and Methods: 76 consecutive, unselected patients who had undergone primary SSV surgery for CVD over a four year time span were included in this retrospective study. Diagnosis of superficial vein thrombosis of the SSV and of Deep Venous Thrombosis (DVT) was made by means of patient history and preoperative Duplex Ultrasonography Findings (DUS).

Results: In 28 patients (36.8%) (36 legs) a condition after superficial vein thrombosis was diagnosed. Thromboembolic complications such as deep venous thrombosis and Pulmonary Embolism (PE) occurred in 11 of 76 patients (14.4%). All of these patients suffered from superficial vein thrombosis.

Conclusion: We conclude that studies on superficial vein thrombosis of the SSV and possible thromboembolic complications are rarely found in the literature. The morbidity associated with SSV insufficiency may be underestimated.

Aim: End-Stage Renal Disease (ESRD) patients on renal replacement therapy have increased cardiovascular morbidity and mortality rate and are at high risk for the development of Abdominal Aortic Aneurysms (ΑΑΑs). The aim of the present study was to investigate the management and outcome of ΑΑΑs in chronic hemodialysis patients.

Patients-Methods: During the period 2010-2015, an AAA was diagnosed in 19 ESRD patients. Thirteen out of them underwent Endovascular Aneurysm Repair (EVAR), 1 patient underwent Open Surgical Repair (OSR) and 5 patients were on regular follow-up.

Results: During the 6 year follow-up period, an endoleak was recorded in 7 out of the 13 aneurysms (36.8%). Endoleak was an early complication in one patient (14.3%) and late in six (85.7%) and was successfully managed with a repetitive EVAR in all cases. Five patients (26.3%) died including the patient who underwent OSR. The causes of death were sepsis in 3 patients (60%), device migration and aneurysm rupture in 1 patient (20%) and cerebrovascular accident in 1 patient (20%).

Conclusions: In end-stage renal disease patients with abdominal aortic aneurysms, EVAR is a safe therapeutic option with low both peri-operative and long-term morbidity and mortality.